No update because they already gave us a timeline of March to...

No update because they already gave us a timeline of March to April for an update. I believe we are still in February. In my opinion I think management did some great work last year. They were aggressive and tried for a fastracked global launch in early markets last year, they failed, but atleast they had the target set and worked towards it. Something bad definitely happened last quarter that caused them to fail to achieve commercialisation. They should have just disclosed it openly instead of sugar coating as a change in protocol. Anyways hopefully everything is back on track this year and by April commercialisation is achieved . Small tech biotechs always come with risks... so always be prepared for big losses and big gains.